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Objective: The goal of the present study was to define the early and late func-
tional results after revascularization in ischemic cardiomyopathy and to
identify variables predictive of a favorable outcome.
Methods: A retrospective review of all consecutive patients with ischemic
cardiomyopathy undergoing myocardial revascularization between January
1991 and June 1998 was undertaken. One hundred sixty-seven patients (140
men) aged 60 ± 8 years (range, 39-77 years) with angina (n = 107), conges-
tive heart failure (n = 54), or silent ischemia (n = 6) were identified. One
hundred six (63%) patients with angina were in Canadian Cardiovascular
Society class III or IV, and 40 (24%) patients with congestive failure were in
New York Heart Association class III or IV. The preoperative left ventricular
ejection fraction averaged 0.28 ± 0.05 (range, 0.16-0.30). Thirteen (8%)
patients required preoperative mechanical life support. A mean of 2.9 ± 0.9
grafts per patient were performed, with an average myocardial ischemia time
of 53 ± 23 minutes and bypass time of 104 ± 31 minutes.
Results: There were 3 (1.7%) early deaths and 21 (13%) deaths during fol-
low-up (2.7 ± 2.1 years; range, 0.3-7.8 years), producing a survival of 94%
± 2% and 75% ± 10% at 1 and 5 years, respectively. Despite a significant
increase in left ventricular ejection fraction (0.28 ± 0.05 vs 0.38 ± 0.09, P =
.0001), only 89 (54%) patients were symptom-free at follow-up. Freedom
from recurrent angina was 98% ± 1% and 81% ± 8%, whereas freedom from
congestive failure was 78% ± 11% and 47% ± 20% at 1 and 5 years, respec-
tively. Follow-up New York Heart Association class in patients with conges-
tive failure was improved (40/54 class III-IV vs 11/54 class III-IV, P =
.0001). Multivariate analysis showed a lower ejection fraction (P = .01), pre-
operative congestive failure (P = .03), and a need for preoperative intra-aor-
tic balloon pumping (P = .03) to be associated with a greater prevalence of
recurrent congestive failure, whereas male sex (P = .01), preoperative angi-
na (P = .04), use of the internal thoracic artery (P = .03), and higher number
of grafts (P = .01) were associated with lower prevalence. Male sex (P = .06),
higher number of grafts (P = .04), and shorter duration of myocardial
ischemia (P = .04) were also predictive of improvement in New York Heart
Association class at follow-up.
Conclusions: Despite satisfactory early and late survival, late functional out-
come after myocardial revascularization in ischemic cardiomyopathy
remains suboptimal because of recurrence or persistence of congestive fail-
ure. Selection of appropriate surgical candidates and extensive use of com-
plete revascularization with the internal thoracic artery may substantially
improve functional results.  (J Thorac Cardiovasc Surg 2000;120:478-89)
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The rapid extension of heart transplantation to a widercategory of patients with end-stage heart disease in
the late 1980s has been responsible for the increasing
discrepancy between the demand for heart transplanta-
tion and offers of viable donor organs.1 The realization
that high-risk surgical options could be offered to
selected patients initially evaluated as potential trans-
plant recipients led several pilot institutions to redefine
the relative indications for heart transplantation.2-6 It
was readily apparent that a proportion of patients with
end-stage ischemic heart disease could be offered
myocardial revascularization at the expense of greater
operative risk but with an overall early outcome
absolutely comparable with that of heart transplanta-
tion.2,6 The awareness that selection criteria were need-
ed to identify patients who would benefit from revascu-
larization5 promoted the widespread use of laboratory
investigation to identify areas of viable myocardium,
albeit in a quiescent or hibernated state.7-9 Progress in
the field of imaging and metabolic diagnostic tech-
niques, as well as advancements in the strategies of
intraoperative myocardial protection and postoperative
care, must be credited for the significant decrease in
operative risk for patients with ischemic cardiomyopa-
thy undergoing coronary artery bypass surgery
observed in the early 1990s.10-13 Medical management
of congestive heart failure likewise witnessed substan-
tial improvements with the introduction of angiotensin-
converting enzyme inhibitors in clinical practice.14
With the availability of a series of valid medical and
surgical therapeutic options for ischemic cardiomyopa-
thy, it has become necessary to identify more stringent
selection criteria for revascularization. In particular,
negligible attention has thus far been devoted to the
assessment of late functional outcome of patients after
coronary bypass surgery, which must also be taken into
consideration when a treatment option is chosen. The
purpose of the present study was to define the long-
term functional results after myocardial revasculariza-
tion for ischemic cardiomyopathy and to identify fac-
tors predictive of favorable outcome.
Methods
Patient selection. Between January 1991 and June 1998,
5579 consecutive patients with ischemic heart disease under-
went myocardial revascularization (coronary artery bypass
grafting) at our institution. One hundred sixty-seven (2.9%)
had severe left ventricular failure (left ventricular ejection
fraction [LVEF] < 30%) and were thus retrospectively select-
ed for the study. Inclusion criteria throughout the observation
period were clinical (ie, angina) evidence, laboratory (ie, pos-
itive stress test result) evidence, or both, of ischemic heart
disease with angiographic demonstration of critical obstruc-
tive coronary artery lesions. Estimates of LVEF were gath-
ered from biplanar left ventricular angiograms in all patients.
Exclusion criteria were the presence of a recent (ie, <1 month
old) myocardial infarction, the existence of valve disease, or
the existence of a left ventricular aneurysm necessitating sur-
gical treatment. Myocardial viability studies to further identi-
fy suitable surgical candidates were gradually adopted during
the observation period and became routine at our institution
only in 1994. Accordingly, stress and rest-redistribution 201
thallium scintiscan, low-dose dobutamine echocardiography,
or both, were used to image areas of viable (ie, hibernated)
myocardium. Because of cost considerations, positron emis-
sion tomography was used only in cases of inconclusive
response with the aforementioned laboratory investigations
or when both results were negative despite the presence of
angina, as reported in the management algorithm depicted in
Fig 1. The demographic variables of the patient population
are summarized in Table I.
Operative technique. All procedures were performed
through a median sternotomy with the aid of moderately
hypothermic (28°C) cardiopulmonary bypass by using aortic
and right atrial cannulation and left ventricular venting
through the right superior pulmonary vein. Complete
myocardial revascularization with venous and arterial con-
duits was the goal in every patient. Use of the left internal
thoracic artery on the left anterior descending branch was
routinely extended to all patients 70 years old or younger. In
older patients the left internal thoracic artery was used on an
individual basis. All distal coronary anastomoses were per-
formed first. The proximal anastomoses were performed with
total aortic crossclamping or partial occlusion at the sur-
geon’s discretion. Before 1995, myocardial preservation was
obtained by intermittent injection of cold (4°C) crystalloid
cardioplegic solution through the antegrade route. After aor-
tic crossclamping, 1000 mL of St Thomas’ Hospital II solu-
tion was injected into the aortic root at a rate of 150 to 300
mL/min. The dose was continued in case of persistent elec-
trical activity to achieve cardiac standstill. Topical cooling of
the heart with ice-slush was also used. Maintenance doses
(500 mL) of cardioplegic solution were administered every
30 minutes. After 1995, cold blood induction and mainte-
nance and warm reperfusion cardioplegia through the ante-
grade and retrograde (ie, coronary sinus) routes was used
according to Buckberg’s principles.15 A cold (4°C) induction
dose of 10 mL/kg was administered at 150 to 300 mL/kg
through the antegrade (two thirds of dose) and retrograde
(one third of dose) routes. The dose was continued until car-
diac standstill in case of persistent electrical activity.
Maintenance cold doses of 5 mL/kg were administered
through the coronary sinus every 20 minutes. Warm (30°C-
32°C) reperfusion was administered alternatively through the
antegrade or retrograde route at 150 to 300 mL/min for 3
minutes before aortic clamp release. The operative variables
of the patient population are reported in Table II.
Follow-up. Perioperative information was obtained from
hospital records. Cross-sectional follow-up was conducted
between August and September 1998 by telephone interview
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or direct assessment at follow-up physical and laboratory
examination. Patient follow-up was 100% complete.
Statistical analysis.  Data were reported as mean values ±
SD or as proportions. Comparison of continuous variables
was done by a 2-tailed Student t test for paired data. The
Pearson χ2 or Fisher exact tests were used for categoric vari-
ables as appropriate. Survival curves were constructed by the
Kaplan-Meier method. Differences in survival were deter-
mined by the log-rank test. Multivariate correlates of survival
were identified by the Cox proportional hazard method.
Multivariate correlates of hospital death, recurrent angina,
recurrent congestive failure, and improvement of Canadian
Cardiovascular Society (CCS) and New York Heart
Association (NYHA) class at follow-up were determined by
stepwise logistic regression analysis. The list of variables
entered in the analysis is as follows: age, sex, angina, con-
gestive heart failure, silent ischemia, ventricular arrhythmia,
hypertension, hyperlipidemia, diabetes, prior myocardial
infarction, CCS functional class, NYHA functional class, lab-
oratory evidence of viable myocardium, LVEF, prior cardiac
operation, preoperative intra-aortic balloon pumping (IABP),
year of operation, urgent operation, number of grafts, use of
the left internal thoracic artery, duration of myocardial
ischemia, duration of cardiopulmonary bypass, and use of
blood cardioplegia.
The primary end points of the study were as follows: early
mortality (before hospital discharge or within 30 days of
operation), late mortality, cardiac-related mortality (myocar-
dial infarction, congestive heart failure, arrhythmia, or sud-
den death), recurrence of angina, recurrence of heart failure,
and functional outcome. Functional outcome was evaluated
by comparison of preoperative and 6-month follow-up
echocardiographic measurements of LVEF, preoperative and
follow-up clinical status according to the NYHA for conges-
tive heart failure and CCS for angina, and evaluation of qual-
Fig 1.  Management algorithm for patients with ischemic cardiomyopathy. A thallium scan is defined as stress
thallium-201 single-photon emission computed tomography with reinjection at rest before redistribution, and
dobutamine echocardiography (ECHO) is defined as low-dose (5-10 µg) and high-dose (10-20 µg) dobutamine
stress echocardiography. CABG, Coronary artery bypass grafting; TMR, transmyocardial laser revasculariza-
tion; Htx, heart transplantation; PET, fluoro-18-deoxyglucose positron emission tomography.
Table I. Demographic data
No. of patients 167
Sex (M/F) 140/27
Age (y) 60 ± 8 (39-77)*
Hypertension 65 (38.9%)
Diabetes mellitus 40 (24.0%)
Hyperlipidemia 65 (38.9%)
Prior MI 157 (94.0%)
Episodes of MI per patient 1.2 ± 0.4 (1-3)*
Angina 146 (87.4%)
Congestive heart failure 54 (32.3%)
Silent ischemia 6 (3.6%)
Ventricular arrhythmias 8 (4.7%)
Class III-IV CCS 106 (63.5%)
Class III-IV NYHA 40 (24.0%)
Three-vessel disease 114 (68.3%)
LVEF 0.28 ± 0.05 (0.16-0.30)*
Myocardial viability study 81 (48.5%) 
MI, Myocardial infarction; CCS, Canadian Cardiovascular Society; NYHA,
New York Heart Association.
*Range is given in parentheses.
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ity of life. The latter was assessed by means of a simplified
self-administered questionnaire, which examined prevalence
of active employment and severity of subjective physical lim-
itation (graded as limited activity, partial limitation, or no
limitation).
Results
Early clinical outcome. There were 3 (1.7%) early
deaths, all of which were of a cardiac cause. One
patient died on the second postoperative day as a result
of low cardiac output after perioperative myocardial
infarction, despite mechanical life support with a left
ventricular assist device. The second casualty was in a
patient undergoing the third myocardial revasculariza-
tion procedure for unstable angina, who manifested
irreversible low output syndrome refractory to IABP
and high-dose catecholamine support. Perioperative
myocardial infarction was ruled out on the basis of lab-
oratory and electrocardiographic findings. The third
early death occurred in a patient with silent ischemia
and a history of ventricular tachyarrhythmia who had
an unremarkable recovery in the intensive care unit but
experienced ventricular fibrillation on the regular ward.
Univariate analysis demonstrated that angina was asso-
ciated with a decreased risk of hospital mortality (P =
.04), whereas prolonged duration of cardiopulmonary
bypass was associated with an increased risk of the
same event (P = .03). When entered into the multivari-
ate analysis, none of the variables examined proved
predictive. 
Major nonfatal postoperative complications were
observed in 40 (24%) patients. Postoperative myocar-
dial infarction was diagnosed in 9 (5%) patients, 8 of
whom required catecholamine and IABP support.
Fourteen (8%) additional patients showed reversible
low cardiac output syndrome in the absence of labora-
tory and electrocardiographic evidence of perioperative
myocardial infarction. Hemodynamic stabilization was
achieved by means of IABP support in 3 of these
patients, 2 of whom had required preoperative IABP
support as well. Life-threatening ventricular arrhyth-
Table II. Operative data
Prior CABG 9 (5.3%)
Urgent operation 24 (14.4%)
Preoperative IABP support 13 (7.7%)
Grafts per patient 2.9 ± 0.9 (1-5)*
LITA graft 104 (62.3%)
Aortic crossclamp (min) 53 ± 23 (19-95)*
CPB (min) 104 ± 31 (34-208)*
Blood cardioplegia 109 (65.3%)
CABG, Coronary artery bypass grafting; LITA, left internal thoracic artery;
CPB, cardiopulmonary bypass.
*Range is given in parentheses.
Table III. Correlates of late mortality
Variable β Factor P value
Preoperative LVEF –7.99 .07
No. of bypass grafts –0.69 .03
Duration of CPB 0.02 .07
Multivariate analysis with Cox model. LVEF, Left ventricular ejection frac-
tion; CPB, cardiopulmonary bypass.
Fig 2. Overall survival of 167 patients with ischemic cardiomyopathy undergoing myocardial revascularization at
the University of Verona between January 1991 and June 1998. Dashed lines represent 70% confidence limits.
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mias were recorded in 5 (3%) patients, 1 of whom
needed resuscitation with open-chest cardiac massage
and an IABP, subsequently. Emergency repeat coro-
nary angiography in the latter patient demonstrated
patency of all the bypass grafts. Four (2%) patients
required prolonged mechanical ventilatory support for
respiratory failure. Two (1%) patients had a postopera-
tive cerebrovascular accident, and 1 had acute renal
failure necessitating dialysis. Postoperative bleeding
leading to re-exploration occurred in 3 (2%) patients.
Late clinical outcome. Twenty-one late casualties
were recorded during a follow-up period ranging from
0.3 to 7.8 years (mean, 2.7 ± 2.1 years). Actuarial sur-
vival was 94% ± 2%, 75% ± 8%, and 75% ± 8% at 1,
5, and 7 years, respectively (Fig 2). Cause of late mor-
tality was cardiac in 15 patients (progressive heart fail-
ure in 7, sudden death in 5, and myocardial infarction
in 3), giving an actuarial freedom from cardiac death of
95% ± 1%, 84% ± 5%, and 84% ± 5% at 1, 5, and 7
years, respectively. Noncardiac cause of death included
malignancy in 5 patients and stroke in 1 patient.
Multivariate analysis showed the number of bypass
grafts and ejection fraction to be inversely correlated
with late mortality, whereas duration of cardiopul-
monary bypass was directly correlated with it (Table
III). The significance of the following findings
increased when late cardiac mortality was used as an
end point (Table IV).
Late complications, excluding those of cardiac origin
that are reported below, were cerebrovascular accident
in 2 patients and right leg amputation in a patient with
severe peripheral vascular disease.
Late functional outcome. Laboratory evidence of
successful functional outcome of myocardial revascu-
larization was suggested by a significant improvement
in ejection fraction at 6-month follow-up echocardiog-
raphy (0.28 ± 0.05 vs 0.38 ± 0.09, P = .001). However,
no correlates predictive of increase in ejection fraction
could be isolated, possibly because of the wide distrib-
ution of follow-up values.
Eighty-nine (54%) of 164 operative survivors were
symptom-free at follow-up assessment. Actuarial
symptom-free survival for the entire patient population
was 75% ± 8%, 41% ± 16%, and 31% ± 18% at 1, 5,
and 7 years, respectively (Fig 3).
Recurrent angina was diagnosed in 17 (10%) opera-
tive survivors, 7 of whom had associated congestive
failure. Fourteen of these patients had presented with
angina at operation, whereas 3 had been referred for
angina combined with congestive heart failure (Fig 4).
Four of 10 patients with angina alone at follow-up had
elective repeat coronary angiography, which showed
patency of all 3 bypass grafts in 1 patient, of 2 of 3
grafts in 1 patient, of 1 of 3 grafts in 1 patient, and
Fig 3. Overall symptom-free survival of 167 patients with ischemic cardiomyopathy undergoing myocardial
revascularization at the University of Verona between January 1991 and June 1998. Dashed lines represent 70%
confidence limits.
Table IV. Correlates of late cardiac-related mortality
Variable β Factor P value
Preoperative LVEF –5.55 .06
No. of bypass grafts –0.30 .06
Duration of CPB 0.04 .04
Multivariate analysis with Cox model. LVEF, Left ventricular ejection frac-
tion; CPB, cardiopulmonary bypass.
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occlusion of all grafts in the last patient. Two of the 4
patients undergoing repeat invasive evaluation received
a percutaneous transluminal coronary angioplasty dur-
ing the procedure, whereas the remaining patients with
recurrent angina or mixed symptoms were assigned to
medical treatment and showed either clinical improve-
ment or stabilization. Actuarial freedom from recurrent
angina was 98% ± 1%, 81% ± 8%, and 63% ± 10% at
1, 5, and 7 years, respectively (Fig 5). No correlates of
recurrent angina could be disclosed.
Fig 4. Diagram depicting the evolution of the clinical picture of 167 patients with ischemic cardiomyopathy
undergoing myocardial revascularization at the University of Verona between January 1991 and June 1998. Note
that the total number of patients at follow-up is 164, corresponding to the operative survivors. CHF, Congestive
heart failure.
Fig 5. Overall angina-free survival of 167 patients with ischemic cardiomyopathy undergoing myocardial revascu-
larization at the University of Verona between January 1991 and June 1998. Dashed lines represent 70% confidence
limits. 
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Congestive heart failure was observed in 65 (40%)
operative survivors at follow-up, 7 of whom manifest-
ed recurrent angina, as specified above. Thus actuarial
freedom from recurrent congestive failure was 78% ±
10%, 47% ± 20%, and 42% ± 22% at 1, 5, and 7 years,
respectively (Fig 6). Although all patients with recur-
rent angina had the same as a presenting symptom, this
did not apply to patients showing recurrent, persistent,
or newly diagnosed heart failure. The variability of the
evolution of clinical status as related to the type of
symptom at follow-up is depicted in Fig 4. Three
patients with rapidly progressing congestive failure and
absence of viable myocardium at follow-up evaluation
were listed for heart transplantation. The remaining
were maintained on medical therapy alone. Several
variables were identified as correlates of recurrent heart
failure. In particular, lower LVEF, presentation with
congestive failure, and need for preoperative IABP
were associated with a greater likelihood, whereas
male sex, preoperative angina, use of a left internal tho-
racic graft, and greater number of bypass grafts were
associated with a lesser likelihood of congestive heart
failure at follow-up (Table V). Average CCS functional
class for the entire population improved from 2.8 ± 0.9
to 1.7 ± 0.5 at follow-up (P = .01), whereas improve-
ment in average NYHA functional class was not evi-
dent (1.6 ± 0.9 vs 1.7 ± 0.8, not significant), possibly
because of the high prevalence of congestive heart fail-
ure at follow-up evaluation. When only patients pre-
senting with heart failure were examined, however, a
significant improvement in NYHA class was disclosed,
as attested to by the shift of patients toward lower func-
tional classes (40/54 patients preoperatively vs 11/54
patients postoperatively in NYHA class III-IV,
P = .001). Multivariate correlates of improvement in
CCS functional class could not be identified. On the
contrary, male sex, presentation with angina, and high-
er number of bypass grafts had a positive predictive
effect of improvement in NYHA class, whereas longer
duration of myocardial ischemia had a negative predic-
tive effect (Table VI).
Fig 6. Overall congestive heart failure–free survival of 167 patients with ischemic cardiomyopathy undergoing
myocardial revascularization at the University of Verona between January 1991 and June 1998. Dashed lines rep-
resent 70% confidence limits.
Table V.  Correlates of recurrent CHF
Variable Odds ratio P value
Male sex 0.28 .01
LVEF 0.48 .01
CHF 1.40 .03
Angina 0.93 .04
Preoperative IABP 3.34 .03
Use of LITA 0.84 .03
No. of bypass grafts 0.99 .01
Multivariate analysis with regression model. LVEF, Left ventricular ejection
fraction; CHF, congestive heart failure; IABP, intra-aortic balloon pumping;
LITA, left internal thoracic artery.
Table VI. Correlates of NYHA class variation
Variable β Factor P value
Angina –0.12 .02
Male sex –0.14 .06
Aortic crossclamp 0.19 .04
No. of bypass grafts –0.18 .04
Multivariate analysis with Cox model. NYHA, New York Heart Association.
A simplified, self-administered quality-of-life ques-
tionnaire was administered to all 143 long-term sur-
vivors (median age at follow-up of 65 years; range, 46-
79 years), and 123 (90%) of them responded.
Twenty-two patients had returned to active employ-
ment, representing 18% of the overall population and
36% of the patients below retirement age. Thirty-seven
(29%) patients felt physically limited in their daily
activity, 21 (16%) felt only partially limited, and 70
(55%) felt no limitation at all.
Discussion
Survival. Myocardial revascularization has evolved
into a safe treatment modality for selected patients with
ischemic cardiomyopathy. The present work demon-
strates that coronary artery bypass grafting can nowa-
days be offered to patients with ischemic left ventricu-
lar failure at a low operative risk (as low as 2%) and
with a satisfactory long-term outlook.
Comparison of survival estimates after myocardial
revascularization with previously published series pre-
sents some shortcomings. In particular, patient selection
criteria are not uniform among the various clinical
reports, as regards the upper-end limit of LVEF and the
inclusion of patients with acute myocardial infarction,
left ventricular aneurysm, or valve disease necessitating
surgical treatment.16 The clinical results further differ
whether referred to comprehensive series of consecutive
patients10,13,17 or to limited cohorts of patients selected on
the basis of detection of viable myocardium.11,12 These
limitations notwithstanding, an operative mortality rang-
ing from 2% to 10% has recently been reported for large
(ie, 100 or more consecutive patients) clinical series by
Kaul,10 Trachiotis,13 Christakis,17 and Langenburg,18 and
their colleagues. Detailed analysis of the present experi-
ence shows that aside from a very low operative mortali-
ty, in line with the estimates quoted above, surgical revas-
cularization still imposes substantial cardiac morbidity to
patients with ischemic cardiomyopathy (myocardial
infarction, 5%; low output syndrome, 8%; IABP use,
13%). This observation is entirely consistent with the
findings of Christakis and associates17 (myocardial
infarction, 11%; low output, 31%; IABP use, 16%) and
partly with those of Trachiotis and associates13 (myocar-
dial infarction, 1%; IABP use, 11%). Long-term outcome
after myocardial revascularization is also satisfactory in
the present study and in agreement with previously
reported actuarial 5-year survivals between 64% and
73%.10,13 Progress in perioperative management of
patients with end-stage ischemic heart disease19 has been
instrumental in turning bypass grafting from a high-risk
neglected alternative to transplantation3-6 into a low-risk
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routine treatment modality. However, an even more
important role has been played by the constant evolution
throughout the last decade of time of patient selection cri-
teria by means of prospective laboratory investigation
and of retrospective risk stratification.10-13,17,20,21
Accordingly, reviews of large clinical series, such as
the current one, have been carried out to isolate preop-
erative or intraoperative variables, which may predict
the outcome of revascularization. Analysis of previous
work shows that a series of patient characteristics may
be associated with increased operative risk, including
advanced age, female sex, lower ejection fraction,
comorbid conditions, urgency of operation, and reoper-
ation.10,13,17,20 Unfortunately, identification of factors
predictive of early mortality proved unrewarding in the
present experience, likely because of the very low num-
ber of events. On the contrary, both late overall and late
cardiac mortality were associated with lower ejection
fraction, lower number of bypass grafts, and longer
duration of cardiopulmonary bypass. The relation
between preoperative ejection fraction and long-term
survival is intuitive because it may describe the severi-
ty of ischemic left ventricular failure. A similar corre-
lation was also disclosed by Trachiotis and associ-
ates,13 but not by Kaul and coworkers,10 possibly
because their study was limited to patients with ejec-
tion fractions below 20%. The number of bypass grafts
in the current series expresses the completeness of
revascularization because two thirds of patients had 3-
vessel disease. Thus, the finding of an inverse relation
between the number of grafts and late mortality once
again matches the results of Trachiotis and col-
leagues,13 who found complete myocardial revascular-
ization to be inversely correlated with late death. Both
studies extend to ischemic cardiomyopathy, the princi-
ple that ability to completely revascularize the
myocardium is of great prognostic significance for sur-
vival, as shown for coronary operations in general.22
Understanding of the role of duration of cardiopul-
monary bypass, an operative variable indicative of
more complex or complicated procedures, in predicting
late survival is less immediate. This factor may also
express the severity and extension of ischemic heart
disease, whereby longer circulatory assistance may be
required to wean a failing heart from bypass.
Functional outcome. Although most of the research
efforts have focused on the demonstration that early
and late survival after myocardial revascularization is
indeed satisfactory, few studies have concentrated on
the functional outcome after operation. The demonstra-
tion of a short-term improvement in LVEF has general-
ly been regarded as an index of successful functional
result.5,6,8,9,11,23 Contrary to this assumption, more
recent evidence has clearly shown that increase in left
ventricular systolic performance is not necessarily
accompanied by clinical improvement, as it can be
measured by NYHA classification, exercise capacity,
or quality-of-life scores.12,24-27 These findings are of
great relevance because medical management of con-
gestive heart failure has also witnessed significant
progress in terms of both survival and control of symp-
toms.14 Thus, the choice of the optimal treatment
modality in the individual patient with ischemic car-
diomyopathy has nowadays become more difficult.
Simply looking for a survival benefit may be insuffi-
cient to discriminate among therapeutic alternatives.
The present experience shows that recurrence of
symptoms late after operation remains a definite prob-
lem, despite successful functional outcome, as tradi-
tionally evaluated by an increase in LVEF (from 28% to
38%). In general, a 5-year symptom-free survival of
41% can hardly be considered satisfactory. Closer
scrutiny of late functional outcome reveals that revas-
cularization in ischemic cardiomyopathy offers durable
relief from angina because more than 80% of patients
are likely to be free from angina 5 years after operation.
These results favorably compare with the raw estimates
quoted by Trachiotis and colleagues13 (40% prevalence
of return of angina at 5.8 years’ mean follow-up) and by
Kaul and colleagues10 (35% prevalence at 3.6 years),
albeit at a shorter average period of observation (10%
prevalence at 2.7 years in the current series). Although
generally found in patients who had angina as a pre-
senting symptom, no variable proved predictive of
recurrence in the present experience, once again
because of the low number of events recorded during
follow-up. Thus, it remains purely speculative whether
this discrepancy in outcome, as well as the ability to
adequately control recurrent angina simply by augmen-
tation of medical therapy and interventional proce-
dures, may be related to the more extensive use (62%
of patients vs 20%-35% in the previous series10,13) of
the left internal thoracic artery as the conduit of choice
for the left anterior descending artery, as demonstrated
in the common coronary surgery population.28 Arterial
revascularization may also have the potential for saving
these critically ill patients from reoperation, which car-
ries a high risk.29
As a corollary to the aforementioned observations,
congestive heart failure is primarily responsible for the
disappointingly high prevalence of persistence or return
of symptoms late after operation. This is evident by the
extent of overlap between the two respective survival
curves (Figs 3 and 6). Estimates of recurrent heart fail-
ure are uncommonly reported and vary widely among
series of patients with ischemic cardiomyopathy, rang-
ing from 28% to 63%12,26,30; the present result (ie,
40%) is consistent with previous findings. Unlike angi-
na, congestive heart failure may present in any patient
subgroup, which is attested to by the fact that half of
the symptomatic patients had originally presented with
angina and were free from it at follow-up. It is con-
ceivable that de novo appearance of heart failure
expresses the relentless evolution toward left ventricu-
lar insufficiency, which would not be recognized by
short-term echocardiographic assessment as it was car-
ried out in this study and in the majority of previous
studies.5,6,8,11,12,23,25,26 Longitudinal measurement of
LVEF is warranted to disclose the relation, if any,
between left ventricular systolic function and conges-
tive heart failure late after operation.
Predicting the recurrence or appearance of heart fail-
ure has enormous bearing in terms of patient selection,
given that late survival after bypass grafting and trans-
plantation is similar, but the quality of life with the lat-
ter is affected by the need for long-term medication and
the attendant risks of immunosuppression. In the pre-
sent experience, female sex, history of congestive fail-
ure, lower ejection fraction, and need for preoperative
IABP support were associated with greater likelihood
of heart failure at follow-up. On the contrary, history of
angina, use of the left internal thoracic artery, and num-
ber of bypass grafts were inversely associated with
return of congestive failure. The meaning of clinical
variables is rather apparent, even though a relation with
recurrent heart failure has never been previously pro-
posed. In fact, female sex has often been associated
with adverse late outcome after revascularization in
ischemic cardiomyopathy, as have history of conges-
tive failure and lower ejection fraction.10,13 The need
for preoperative IABP may further identify patients
with more severe left ventricular insufficiency.
Comparison with existing data is troublesome because
few investigators have analyzed return of heart failure
in large clinical series. Yamaguchi and colleagues30
found diabetes and preoperative left ventricular end-
systolic volume index (>100 mL/m2), but not history of
congestive failure, to be predictive of recurrent heart
failure in 39 operative survivors followed up for a mean
of 3.6 years. The smaller number of patients and the
higher proportion with preoperative heart failure (31/41
[76%] vs 54/167 [32%]) can account for the discrepan-
cy with the present findings. Whereas the demographic
characteristics isolated have an effect on patient selec-
tion, the operative variables identified herein have rele-
vant therapeutic implications. Indeed, the unprecedent-
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ed finding that more extensive use of left internal tho-
racic artery grafts and of complete revascularization
may reduce the prevalence of congestive failure late
after operation corresponds well to similar conclusions
reached by historical studies on the general coronary
bypass population.22,31 Inability to show a correlation
between the type of conduit for revascularization and
late cardiac events or control of symptoms by past stud-
ies on ischemic cardiomyopathy may have been due to
low prevalence of left internal thoracic artery use (ie,
between 20% and 35% when reported).10,13 Common
reasons for not using the internal thoracic artery in
patients with left ventricular failure during the 1980s
were advanced age, urgency of operation, and modest
concern for long-term prognosis.17 The clinical experi-
ence of the past decade has decisively solved these
reservations,10,13 as confirmed by the present work;
therefore, no patient with ischemic cardiomyopathy
should be denied a left internal thoracic artery graft.
Consensus already exists on the importance of com-
plete myocardial revascularization in decreasing the
rate of late adverse events,13 although the specific role
on recurrence of heart failure has not been established
previously.
The substantial prevalence of congestive heart failure
at follow-up explains the absence of improvement in
mean NYHA functional class of the overall population.
It is, however, noteworthy that patients with heart failure
had significant attenuation of symptoms, and half of
them were asymptomatic at follow-up. This suggests
that revascularization may be associated with durable
functional improvement, even in patients with pure con-
gestive failure, although less commonly than in patients
with a history of angina, as shown by the relation
between the latter variable and NYHA class at multi-
variate analysis. Similar to the results obtained with
recurrence of heart failure, male sex and greater number
of bypass grafts were predictive of amelioration in func-
tional class. On the basis of the present results, complete
myocardial revascularization has the potential for
decreasing not only late mortality but also the preva-
lence and severity of congestive failure. It follows that
coronary operations without the use of cardiopulmonary
bypass, by definition associated with incomplete revas-
cularization, are not ideally suited for patients with
ischemic cardiomyopathy, as recently advocated.32
Quality of life was satisfactory in most long-term
survivors of coronary bypass grafting, albeit assessed
by a rather rudimentary questionnaire limited to mobil-
ity status and active employment. Given the profile of
the patient population (large number, advanced age,
and variable social background), it was believed that
compliance to a simplified test would be the greatest.
Although no attempt was made at correlating quality of
life with preoperative parameters, previous studies with
either the Minnesota Living with Heart Failure or the
Nottingham Health Profile have failed to disclose any
relation with clinical or laboratory data.25,27 In particu-
lar, it has been shown that identification of viable
myocardium (≥8 segments at positron emission tomog-
raphy) may predict improvement in LVEF or exercise
capacity but not changes in functional class or quality
of life.25,27
Finally, considering half of the population of long-
term survivors in the present experience was above
retirement age at the time of follow-up, an overall
active employment rate of 18% is not necessarily dis-
appointing. In addition, over 70% of patients felt no or
modest physical limitation in routine physical activity,
which indicates acceptable functional status despite the
high prevalence of persistent or newly presenting heart
failure.
Limitations. The current study presents several lim-
itations. It is retrospective and, like most clinical series
of surgical revascularization in ischemic cardiomyopa-
thy, not randomized. The bias introduced by changing
clinical practice (ie, increasing adoption of blood car-
dioplegia, myocardial viability tests, and use of the left
internal thoracic artery) cannot be easily quantified.
Late follow-up echocardiographic and, most important,
coronary angiographic examinations were not per-
formed. It is difficult to understand whether unsatisfac-
tory functional outcome is a result of progressing left
ventricular insufficiency in turn because of the natural
history of bypass grafts or alternatively because of a
relentless evolution of the myopathy. This shortcoming
afflicts all previously published clinical series. Use of
NYHA and CCS classification to measure clinical and
functional status has inherent limitations. Different
methods, such as the Specific Activity Scale, have
instead been proposed, which have greater agreement
with exercise treadmill performance.33 Nonetheless,
NYHA and CCS remain the most commonly adopted
scoring systems, and continued use is warranted if clin-
ical series are to be compared.
Conclusions
The present study demonstrates that operative and
late survival after myocardial revascularization in
ischemic cardiomyopathy is satisfactory. Whereas
durable relief from angina can be expected in the
majority of long-term survivors, persistence of conges-
tive heart failure, albeit of lesser severity, or its new
appearance represent concerning problems in the late
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follow-up. Patients who present with pure congestive
heart failure and lower ejection fractions are at higher
risk for late death and return of congestive failure.
However, they should not be denied revascularization
solely on this basis because evidence for clinical
improvement exists. Regardless of the clinical sub-
strate, extension to all patients of complete myocardial
revascularization and use of the left internal thoracic
artery graft is strongly recommended because it may
reduce the mortality and the prevalence and severity of
recurrent congestive failure late after the operation.
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